CRISPR study finds new cancer immunotherapy target
from Yale News
A new Yale-led study has discovered a novel gene target for cancer immunotherapy. By using the genome editing system CRISPR to screen for genes, the study determined that the Dhx37 gene modulates the activation of CD8 T cells, which are key players in the immune response against tumors.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063